<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01232179</url>
  </required_header>
  <id_info>
    <org_study_id>88100</org_study_id>
    <nct_id>NCT01232179</nct_id>
  </id_info>
  <brief_title>Comparison of Two Laser Therapy Methods for PDR</brief_title>
  <acronym>PDR</acronym>
  <official_title>Comparison Between Result and Side Effects of Treatment of Prolifrative Diabetic Retinopaty by Conventional and Extended Targeted Pan Retinal Photocoagolation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University of Medical Sciences</source>
  <brief_summary>
    <textblock>
      Proliferative diabetic retinopathy (PDR) is treated with conventional pan retinal
      photocoagulation (PRP) which can improve the visual prognosis in this complication
      significantly. However , the treatment may also resulting adverse effects such as blurring of
      central vision, visual field constriction and disturbance in dark adaptation and contrast
      vision. Extended targeted retinal coagulation (TRP) to the ischemic areas may cause
      regression of the neovascularization while minimizing some of the risks and complication
      associated of treatment of PDR with these two methods.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">May 2011</completion_date>
  <primary_completion_date type="Anticipated">April 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>no leakage in widefield fluorescin angiography</measure>
    <time_frame>3 months after lasertraphy</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Proiriftrative Diabetic Retinopathy</condition>
  <arm_group>
    <arm_group_label>conventional prp</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>targeted PRP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional prp</intervention_name>
    <description>pan retinal photocoagulation</description>
    <arm_group_label>conventional prp</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>targeted prp</intervention_name>
    <description>1200-1600 spot in far periphery retin, anterior equator</description>
    <arm_group_label>targeted PRP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with PDR condidate for photocoagulation teraphy

          -  Pupil with dilatasionâ‰¥6mm

          -  without privious treatment with anti VEGF drugs 3months before study

          -  without privious vitroretinal sugery

          -  without privoius lasertraphy

        Exclusion Criteria:

          -  To have NVI cricteria with increase of inraocular pressure

          -  to have cataract or vitrus leakage which prevent lasertraphy

          -  pupil smaller that 6mm

          -  traditional retinal detachment

          -  privious treatment with anti VEGF drugs 3months before study

          -  privious PRP

          -  patient unable to get wide field FAG
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Labbafinejad medical center</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Masoud Soheilian, proffesor</last_name>
      <phone>00982122585952</phone>
      <email>masoud_soheilian@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>masoud soheilian, proffesor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 1, 2010</study_first_submitted>
  <study_first_submitted_qc>November 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2010</study_first_posted>
  <last_update_submitted>November 1, 2010</last_update_submitted>
  <last_update_submitted_qc>November 1, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 2, 2010</last_update_posted>
  <responsible_party>
    <name_title>Masoud Soheilian</name_title>
    <organization>Ophthalmic Research center</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

